Where Clinical Research Thrives
Location: United States, Texas, San Antonio
Employees: 51-200
Founded date: 2021
Investors 3
| Date | Name | Website |
| 08.11.2021 | NMS Capita... | nms-capita... |
| 10.07.2026 | Genstar Ca... | gencap.com |
| - | Maranon Ca... | maranoncap... |
Mentions in press and media 20
| Date | Title | Description |
| 06.10.2025 | Flourish Research Establishes Meaningful Presence in Oncology with Strategic Investment in Valkyrie Clinical Trials | Partnership Broadens Access to Advanced Cancer Clinical Trials and Strengthens Flourish’s Presence in Southern California APEX, N.C., Oct. 6, 2025—Flourish Research (“Flourish”), a leading multi-site clinical trial organization focused prim... |
| 25.02.2025 | Genstar Announces 2025 Team Promotions | Scott Niehaus and Sid Ramakrishnan to Managing Director and Conor Flemming and Michael Waller to Principal San Francisco, February 25, 2025—Genstar Capital, a leading private equity firm focused on investments in targeted segments of the fi... |
| 18.02.2025 | Flourish Research Announces Strategic Acquisition of Diablo Clinical Research | Clinical Research Facility Expands Flourish Research’s Geographic Footprint and Adds Additional Therapeutic Coverage APEX, NC, February 18, 2025—Flourish Research (“Flourish” or the “Company”), a leading multi-site clinical trial organizati... |
| 07.11.2024 | NMS Capital Exits Investment in Flourish Research | New York, NY, November 7, 2024 – NMS Capital (“NMS”), a leading private equity firm focused on investments within subsectors of Healthcare Services and Business Services, today announced that it has exited its investment in Flourish Researc... |
| 19.09.2024 | Flourish Research Receives Majority Investment from Genstar Capital | Flourish Research, an Apex, NC-based multi-site clinical trial organization focused on cardiovascular, metabolic, neuroscience, and infectious disease therapeutic areas, received a majority investment from Genstar Capital. The amount of the... |
| 18.09.2024 | Flourish Research Announces Strategic Majority Investment from Genstar Capital | Investment to bolster leading multi-site clinical trial organization to further scale across therapeutic areas and geographies APEX, NC and SAN FRANCISCO, CA, September 18, 2024—Flourish Research (“Flourish” or the “Company”), an NMS Capita... |
| 25.06.2024 | NMS Capital Portfolio Company Flourish Research Announces Partnership with ENCORE™ Research Group | New York, NY, June 25, 2024 – NMS Capital (“NMS”) portfolio company Flourish Research (“Flourish”) announced today that it has partnered with ENCORE™ Research Group (“ENCORE” or the “Company”). ENCORE™ is a leading clinical research organiz... |
| 14.11.2023 | NMS Capital Portfolio Company Flourish Research Announces Partnership with Merritt Island Medical Research, Further Expanding Presence in Neuroscience | New York, NY, November 14, 2023 – NMS Capital (“NMS”) portfolio company Flourish Research (“Flourish”) announced today that it has partnered with Merritt Island Medical Research (“MIMR” or the “Company”). MIMR is a leading clinical research... |
| 15.09.2023 | NMS Capital Portfolio Company Flourish Research Announces Partnership with Valley Clinical Trials Marking the Ninth Acquisition Since the Formation of Flourish in 2021 | New York, NY, September 15, 2023 – NMS Capital (“NMS”) portfolio company Flourish Research (“Flourish”) is pleased to announce the acquisition of Valley Clinical Trials (“Valley” or the “Company”). Valley is a leading clinical research site... |
| 29.06.2023 | Jose Alvarez Joins Flourish Research as Chief Operating Officer | Jose Alvarez, COO, Flourish Research I look forward to joining this amazing mission-driven team and sharing my experiences building and developing fast-growing organizations. - Jose Alvarez, COO, Flourish Research NEW YORK (PRWEB) June 29, ... |
Show more